ATAO · Altair International Corp. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $31.88M | $20.75M | - | - | - | - |
| Cost of Revenue | $28.49M | $18.36M | - | - | - | - |
| Gross Profit | $3.39M | $2.39M | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $4.38M | $1.99M | $96.2K | $173.7K | $171.5K | $3.5K |
| Total Operating Expenses | $6.09M | $3.55M | $457.5K | $2.03M | $3.5K | - |
| D&A | $744.6K | $670.4K | - | - | - | - |
| Operating Income | ($2.70M) | ($1.15M) | ($457.5K) | ($2.03M) | ($3.5K) | - |
| Interest Expense | $1.36M | $125.2K | $195.5K | $565.1K | $170.5K | $1.8K |
| Income Tax | $0 | $0 | - | - | - | - |
| Net Income | ($3.87M) | ($2.19M) | ($1.75M) | ($2.47M) | ($11.99M) | ($5.3K) |
| EPS - Basic | ($0.01) | ($0.01) | - | - | ($0.02) | $0.00 |
| EPS - Diluted | ($0.01) | ($0.01) | - | - | - | - |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $213.2K | $4.3K | $28.9K | $20.9K | $122.2K | $26 |
| Accounts Receivable | $2.90M | $311.0K | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | - | - | $3.5K | - | $70.3K | $8.2K |
| Current Assets | $3.73M | $10.8K | $36.9K | $290.9K | $132.2K | $1.8K |
| Total Assets | $36.05M | $10.8K | $36.9K | $290.9K | $232.2K | $1.8K |
| Current Liabilities | $16.33M | $193.4K | $183.1K | $275.5K | $286.8K | $55.5K |
| Long-term Debt | $0 | $81.9K | - | - | - | - |
| Total Liabilities | $32.08M | $193.4K | $183.1K | $275.5K | $611.8K | $55.5K |
| Stockholders' Equity | $3.97M | ($182.6K) | ($146.2K) | $15.5K | ($379.7K) | ($53.7K) |
| Retained Earnings | ($5.75M) | ($17.52M) | ($17.12M) | ($15.37M) | ($12.90M) | ($901.1K) |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.15M | $3.09M | ($142.0K) | ($396.2K) | ($342.4K) | ($110) |
| Investing Cash Flow | ($2.82M) | ($928.6K) | - | - | ($75.0K) | - |
| Financing Cash Flow | $1.65M | ($2.07M) | $150.0K | $295.0K | $539.5K | - |
| CapEx | $2.55M | $1.49M | - | - | - | - |
| Free Cash Flow | ($1.40M) | $1.60M | - | - | - | - |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 10.6% | 11.5% | - | - | - | - |
| Operating margin | -8.5% | -5.5% | - | - | - | - |
| EBITDA margin | -6.1% | -2.3% | - | - | - | - |
| Net margin | -12.1% | -10.6% | - | - | - | - |
| Free cash flow margin | -4.4% | 7.7% | - | - | - | - |
| FCF / Net income | 0.36 | -0.73 | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 13.8% | 9.6% | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - |
| Return on assets | -10.7% | -20293.0% | -4746.5% | -849.2% | -5166.6% | -289.6% |
| Return on equity | -97.4% | 1199.8% | 1197.3% | -15989.3% | 3159.3% | 9.8% |
| Return on invested capital | -53.7% | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | 0.23 | 0.06 | 0.20 | 1.06 | 0.46 | 0.03 |
| Quick ratio | 0.23 | 0.06 | 0.20 | 1.06 | 0.46 | 0.03 |
| Cash ratio | 0.01 | 0.02 | 0.16 | 0.08 | 0.43 | 0.00 |
| Leverage | ||||||
| Debt / Equity | 0.00 | -0.45 | - | - | - | - |
| Debt / Assets | 0.00 | 7.58 | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | -2.0x | -9.2x | -2.3x | -3.6x | -0.0x | - |
| Equity multiplier | 9.08 | -0.06 | -0.25 | 18.83 | -0.61 | -0.03 |
| Liabilities / Assets | 0.89 | 17.91 | 4.96 | 0.95 | 2.64 | 30.59 |
| Efficiency | ||||||
| Asset turnover | 0.88 | 1921.76 | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | 33d | 5d | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | 53.6% | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - |
| Gross profit growth (YoY) | 41.6% | - | - | - | - | - |
| Operating income growth (YoY) | -134.1% | -151.6% | 77.5% | -58773.5% | - | - |
| Net income growth (YoY) | -76.4% | -25.2% | 29.2% | 79.4% | -228106.3% | 92.5% |
| EPS growth (YoY) | 0.0% | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | - | -24.9% | - | - | -606.8% | -10.8% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Product / service
$31.88M totalCharter Sales$27.37M · 85.9%
Leasing Arrangements$3.95M · 12.4%
Maintenance Revenues$439.0K · 1.4%
Other Revenues$63.3K · 0.2%
Management Fees$51.0K · 0.2%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
0.32
Distress
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
5/9
Neutral
- ✗Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- ✓Current ratio improved
- ✗No share dilution
- ✗Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Surgical & Medical Instruments & Apparatus
Comparing ALTAIR INTERNATIONAL CORP. against the 5 most active filers in the same SIC group.